Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

被引：0
|
作者：
Claire von Mollendorf
Mukhchuluun Ulziibayar
Bradford D. Gessner
Lien Anh Ha Do
Cattram D. Nguyen
Rohini Beavon
Bujinlkham Suuri
Dashtseren Luvsantseren
Dorj Narangerel
Adam Jenney
Eileen M. Dunne
Catherine Satzke
Badarchiin Darmaa
Tuya Mungun
E. Kim Mulholland
机构：
[1] Royal Children’s Hospital,Infection and Immunity, New Vaccines Research Group, Murdoch Children’s Research Institute
[2] The University of Melbourne,Department of Paediatrics
[3] Ministry of Health,National Center for Communicable Diseases (NCCD)
[4] Pfizer Vaccines,Department of Infectious Diseases, The Alfred Hospital
[5] Pfizer Vaccines,Department of Microbiology and Immunology
[6] Ministry of Health,Department of Infectious Disease Epidemiology
[7] Monash University,undefined
[8] The University of Melbourne at the Peter Doherty Institute for Infection and Immunity,undefined
[9] London School of Hygiene and Tropical Medicine,undefined
来源：
BMC Public Health | / 21卷
关键词：
Pneumococcal conjugate vaccine; Mongolia; Adult pneumonia; Surveillance; Indirect PCV impact; Nasopharyngeal carriage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Correction to: Radiographically confirmed pneumonia in Malawian children and associated Pneumococcal carriage after introduction of the 13-valent Pneumococcal conjugate vaccine
    Grace Mzumara
    James Chirombo
    Todd D. Swarthout
    Naor Bar-Zeev
    Philliness Prisca Harawa
    Mohamed Sanusi Jalloh
    Amir Kirolos
    Victoria Mukhula
    Laura Newberry
    Olawale Ogunlade
    Richard Wachepa
    Neil French
    Robert S. Heyderman
    Pui-Ying Iroh Tam
    Pneumonia, 17 (1)
  • [42] Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
    Tian, Jie
    Zheng, Bo
    Yang, Laibao
    Guan, Ying
    Xu, Chunze
    Wang, Weibing
    VACCINE, 2023, 41 (41) : 5979 - 5986
  • [43] Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
    Lee, Hong-Yi
    Hsieh, Yu-Chia
    Liu, Ching-Chuan
    Huang, Yi-Chuan
    Chang, Kuang-Yi
    Chi, Hsin
    Chang, Luan-Yin
    Huang, Yhu-Chering
    Huang, Li-Min
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (02) : 199 - 206
  • [44] Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
    Vadlamudi, Nirma Khatri
    Patrick, David M.
    Hoang, Linda
    Sadarangani, Manish
    Marra, Fawziah
    PLOS ONE, 2020, 15 (09):
  • [45] Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study
    Nasreen, Sharifa
    Wang, Jun
    Marra, Fawziah
    Kwong, Jeffrey C.
    Mcgeer, Allison
    Sadarangani, Manish
    Wilson, Sarah E.
    Fadel, Shaza A.
    THORAX, 2024, 79 (09) : 861 - 869
  • [46] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTS
    Chuck, A.
    Waye, A.
    Zanotti, G.
    Jacobs, P.
    Kellner, J.
    Tyrrell, G.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [47] Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned
    La Vincente, S. F.
    von Mollendorf, C.
    Ulziibayar, M.
    Satzke, C.
    Dashtseren, L.
    Fox, K. K.
    Dunne, E. M.
    Nguyen, C. D.
    de Campo, J.
    de Campo, M.
    Thomson, H.
    Surenkhand, G.
    Demberelsuren, S.
    Bujinlkham, S.
    Do, L. A. H.
    Narangerel, D.
    Cherian, T.
    Mungun, T.
    Mulholland, E. K.
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [48] Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned
    S. F. La Vincente
    C. von Mollendorf
    M. Ulziibayar
    C. Satzke
    L. Dashtseren
    K. K. Fox
    E. M. Dunne
    C. D. Nguyen
    J. de Campo
    M. de Campo
    H. Thomson
    G. Surenkhand
    S. Demberelsuren
    S. Bujinlkham
    L. A. H. Do
    D. Narangerel
    T. Cherian
    T. Mungun
    E. K. Mulholland
    BMC Public Health, 19
  • [49] An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea
    Javati, Sarah
    Masiria, Geraldine
    Elizah, Arthur
    Matlam, John-Paul
    Ford, Rebecca
    Richmond, Peter C.
    Lehmann, Deborah
    Pomat, William S.
    van den Biggelaar, Anita H. J.
    PNEUMONIA, 2020, 12 (01)
  • [50] An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea
    Sarah Javati
    Geraldine Masiria
    Arthur Elizah
    John-Paul Matlam
    Rebecca Ford
    Peter C. Richmond
    Deborah Lehmann
    William S. Pomat
    Anita H. J. van den Biggelaar
    Pneumonia, 12
12345